Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort

Vox Sanguinis

Volumn 105, Issue 4, 2013, Pages 313-318

  Bentley, M J ^a,b   Wilson, A R ^c   Rodgers, G M ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Ogden Internal Medicine   (United States)

^c ARUP LABORATORIES   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

ADAMTS13; Haemolytic uraemic syndrome; Plasma exchange; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura

Indexed keywords

BILIRUBIN; CREATININE; D DIMER; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; ELISA KIT; ENZYME ACTIVITY; ENZYME DEFICIENCY; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; PLASMAPHERESIS; PRIORITY JOURNAL; RETICULOCYTE COUNT; SCORING SYSTEM; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; VON WILLEBRAND FACTOR CLEAVING PROTEINASE DEFICIENCY;

ADAMTS13; HAEMOLYTIC URAEMIC SYNDROME; PLASMA EXCHANGE; THROMBOTIC MICROANGIOPATHY; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; COHORT STUDIES; HUMANS; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 84885483363     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12050     Document Type: Article

References (22)

1. Moake JL: Thrombotic microangiopathies. N Engl J Med 2002; 347:589-600
2. Tsai HM: Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency. Hematol Oncol Clin North Am 2007; 21:609-632
3. Moschcowitz E: Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc 1924; 24:21-24
4. Crowther MA, George JN: Thrombotic thrombocytopenic purpura: 2008 update. Cleve Clin J Med 2008; 75:369-375
5. Shephard KV, Bukowski RM: The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions, and plasma exchange. Semin Hematol 1987; 24:178-193
6. Lara PN, Coe TL, Zhou H, et al.: Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Am J Med 1999; 107:573-579
7. Zbigniew MS, Shaz BH, Bandarenko N, et al.: The new approach to assignment of ASFA categories- introduction to the fourth special issue: clinical applications of therapeutic apheresis. J Clin Apheresis 2007; 22:96-105
8. Sadler JE: Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008; 112:11-17
9. Tsai HM. Physiologic cleavage of vonWillebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996;87:4235-4244
10. Furlan M, Robles R, Lammle B: Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996; 87:4223-4234
11. Moake JL, Rudy CK, Troll JH, et al.: Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombocytopenic purpura. N Engl J Med 1982; 307:1432-1435
12. Bentley MJ, Lehman CM, Blaylock RD, et al.: The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange. Transfusion 2010; 50:1654-1664
13. Crist RA, Rodgers GM: A comparison of two commercial ADAMTS13 activity assays with a reference laboratory method. Lab Med 2009; 40:232-235
14. Groot E, Hulstein JJ, Rison CN, et al.: FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura. J Thromb Haemost 2006; 4:698-699
15. Wells PS, Anderson DR, Rodger M, et al.: Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83:416-420
16. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41
17. Levey AS, Bosch JP, Lewis JB, et al.: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461-470
18. Colic E, Dieperink H, Titlestad K, et al.: Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study. Lancet 2011; 378:1089-1093
19. Michael M, Elliott EJ, Ridley GF, et al.: Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura (Review). Cochrane Database Syst Rev 2009; Art. No.: CD 003595.
20. Ohanian M, Cable C, Halka K: Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome. Clin Pharmacol 2011; 3:5-12
21. Larrea CF, Cofan F, Oppenheimer F, et al.: Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation. Transplantation 2010; 89:903-904
22. Mache CJ, Acham-Roschitz B, Frémeaux-Bacchi V, et al.: Complement inhibitor eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009; 8:1312-1316